Welcome to the National Pancreatic Cancer Audit (NPaCA).
The audit will be a really important tool, helping us to accelerate national efforts to improve the care and treatment of patients diagnosed with pancreatic cancer.
It will gather real world information from databases across England and Wales, allowing better comparisons to be made, and revealing where shortfalls need to be addressed.
Pancreatic cancer is one the least survivable cancers, with virtually no improvement seen in survival rates in the UK over 40 years from the 1970s.
But the data that tells us that is ten years old. So, are new treatments having a positive impact?
Ganesh Radhakrishna, one of the clinical leads on the new audit, says pancreatic cancer is very difficult to diagnose and treat, but there is a lot to be optimistic about. And the more data that is gathered the better. You can listen to more of his thoughts here:
Patient charities and support groups have been calling for a national pancreatic cancer audit for a long time. They will play a crucial role in helping us determine which questions need to be addressed most urgently, and what areas of new research might be most beneficial.
Individual patients and carers are also really important to the audit process. We want to hear a wide range of opinions and concerns, both from patients and professionals. The objective is to produce better results for people diagnosed with pancreatic cancer, to try to allow them to live longer, healthier lives.
The clinical leads for NPaCA are as follows:
- Dr Nigel Trudgill, Clinical Lead (Gastroenterology), representing the British Society of Gastroenterology (BSG).
- Mr Andrew Smith, Clinical Lead (Surgery), representing the Association of Upper Gastrointestinal Surgery (AUGIS).
- Dr Ganesh Radhakrishna, Clinical Lead (Clinical Oncology), representing the Royal College of Radiologists (RCR).
This page will be updated whenever more information becomes available. The first results of the audit will start to become available next year, and we intend to keep everyone informed as fully as possible.
Want to find out more? Reach out to us via email.
Email: [email protected]